<?xml version="1.0"?>
<rss version="2.0">
   <channel>
      <title>Predicting Hospital Readmission Rates for Heart Failure Patients Discussion Forum by Axle Training</title>
      <link>https://padlet.com/CarolynKelley/mqro75rxkpnxq68u</link>
      <description></description>
      <language>en-us</language>
      <pubDate>2025-01-13 18:15:15 UTC</pubDate>
      <lastBuildDate>2025-02-19 01:03:05 UTC</lastBuildDate>
      <webMaster>hello@padlet.com</webMaster>
      <image>
         <url></url>
      </image>
      <item>
         <title>The impact and prediction of hospital readmission for HF patients :</title>
         <author></author>
         <link>https://padlet.com/CarolynKelley/mqro75rxkpnxq68u/wish/3295455030</link>
         <description><![CDATA[<p>HF is the leading cause of hospital readmissions effecting patient outcome and creating a significant burden to the healthcare system. The implementation and success of AI-based modeling to predict readmission likeliness among HF patients showed to lower readmission rates by 20% and save the healthcare system $1 million annually. Improving patient care and health outcomes along with lowering healthcare costs benefits both the patient and the medical facility positively impacting quality and efficiency of care.   </p><p><br/></p><p>Sari Mayhue</p>]]></description>
         <enclosure url="" />
         <pubDate>2025-01-18 01:49:20 UTC</pubDate>
         <guid>https://padlet.com/CarolynKelley/mqro75rxkpnxq68u/wish/3295455030</guid>
      </item>
      <item>
         <title></title>
         <author></author>
         <link>https://padlet.com/CarolynKelley/mqro75rxkpnxq68u/wish/3295500124</link>
         <description><![CDATA[<p><br/></p><p><br/></p><p>Predicting hospital readmissions improves patient outcomes and benefits healthcare systems by enabling proactive targeted care that will prevent complications and reduce costs by avoiding unnecessary hospitalizations.</p><p><br/></p><p>As compared to traditional biostatistics models, AI/ML techniques do a better job at handling large complex data and offer superior predictive accuracy in most cases. However, they are less interpretable and require large datasets. As such bias and implementation issues are potential challenges in clinical settings.</p><p><br/></p><p>For AI tools to lead to practical, ethical, and effective solutions in healthcare collaboration between many groups of professional is required: Data scientists design the models, clinicians make sure the solutions are medically relevant, and administrators are&nbsp; needed to manage implementations and guarantee compliance.</p><p><br/></p><p>Mandoye Ndoye</p>]]></description>
         <enclosure url="" />
         <pubDate>2025-01-18 03:57:53 UTC</pubDate>
         <guid>https://padlet.com/CarolynKelley/mqro75rxkpnxq68u/wish/3295500124</guid>
      </item>
      <item>
         <title>AI application for heart failure readmission</title>
         <author></author>
         <link>https://padlet.com/CarolynKelley/mqro75rxkpnxq68u/wish/3295837310</link>
         <description><![CDATA[<p>Heart failure readmissions are not good for patients as it takes them away from their families and lives.  They are also costly and burdensome to the health care system. There are approaches than can reduce admissions but this takes resources so it would be desirable to find a way to focus interventions where they will have the most effect.</p><p><br/></p><p>AI/ML models seems to be able to incorporate more variables into prediction models.  Clinician, scientist and administrators each have different expertise that others may lack. Clinicians and administrators usually lack specific training in AI so the use needs to be explained in a way that may sense and motivates them to make changes in practice based on these results.</p><p><br/></p><p>Beth Thielen</p>]]></description>
         <enclosure url="" />
         <pubDate>2025-01-18 17:11:11 UTC</pubDate>
         <guid>https://padlet.com/CarolynKelley/mqro75rxkpnxq68u/wish/3295837310</guid>
      </item>
      <item>
         <title></title>
         <author></author>
         <link>https://padlet.com/CarolynKelley/mqro75rxkpnxq68u/wish/3297685453</link>
         <description><![CDATA[<ul><li><p>Why is predicting hospital readmission for heart failure patients important for patient outcomes and healthcare systems?</p></li></ul><p>​Predicting hospital readmission for heart failure patients is crucial both for enhancing patient outcomes and improving the efficiency of healthcare systems.​ The ability to forecast readmissions allows healthcare providers to implement timely interventions and optimize care plans for heart failure patients, addressing several significant aspects.</p><p>One of the primary advantages of predicting readmissions is the potential improvement in patient outcomes. When healthcare providers can identify patients at high risk for readmission, they can tailor follow-up care and interventions aimed at reducing this risk. Studies suggest that about 25% of patients with prior heart failure admissions are readmitted within 30 days, and these readmissions are often preventable through better management and follow-up care. More effective post-discharge strategies, such as medication reconciliation and patient education, can significantly reduce the likelihood of readmission, directly impacting patient recovery and health status. By predicting which patients are more likely to be readmitted, healthcare systems can implement preventative measures, potentially improving survival rates and quality of life for these patients.</p><p>&nbsp;</p><p>From a healthcare systems perspective, predicting hospital readmissions can lead to significant economic benefits. Hospital readmissions are a substantial source of healthcare costs. By utilizing predictive models to identify high-risk patients, hospitals can allocate resources more effectively, focusing on intensive management strategies for those most at risk of readmission.</p><p>&nbsp;</p><p>Moreover, studies have shown that employing machine learning and other predictive models can refine the accuracy of identifying patients who might be at risk of readmission, leading to reduced rates of unnecessary hospitalizations. This improved resource allocation not only aids in curtailing hospital costs but also enhances the quality of care delivered to patients, as healthcare providers can dedicate time and attention where it is genuinely needed.</p><p>&nbsp;</p><ul><li><p>What are the advantages and disadvantages of using data science (AI/ML) models compared to traditional biostatistics?</p></li></ul><p>One of the most significant advantages of data science models is their ability to handle vast amounts of diverse data. Unlike traditional biostatistics, which often relies on structured datasets and specific statistical tests, data science can analyze both structured and unstructured data, such as images, text, and sensor data. This capability allows for a more holistic understanding of patient data and leads to richer insights.</p><p>&nbsp;</p><p>Moreover, data science models utilize advanced algorithms that can identify complex patterns and relationships within data that traditional methods might overlook. For example, machine learning models can learn from large datasets to make accurate predictions about patient outcomes or disease risks. This predictive capability enables healthcare providers to implement preemptive interventions, significantly enhancing patient care and outcomes.</p><p>&nbsp;</p><ul><li><p>How does the integration of AI into clinical workflows highlight the need for collaboration between data scientists, clinicians, and administrators?</p></li></ul><p>​The integration of AI into clinical workflows underscores the necessity for collaboration among data scientists, clinicians, and administrators by enhancing decision-making, addressing ethical challenges, and improving workflow efficiency.​ Data scientists develop algorithms that clinicians use for patient care, requiring feedback to ensure practicality and relevance. Additionally, administrators oversee the strategic implementation of AI in healthcare settings, focusing on resource allocation, and overall operational efficiency while ensuring compliance with regulatory standards and ethical considerations. This teamwork fosters innovation and optimizes patient outcomes, highlighting the interconnected nature of their roles in healthcare.</p>]]></description>
         <enclosure url="" />
         <pubDate>2025-01-20 17:42:35 UTC</pubDate>
         <guid>https://padlet.com/CarolynKelley/mqro75rxkpnxq68u/wish/3297685453</guid>
      </item>
      <item>
         <title>•	Why is predicting hospital readmission for heart failure patients important for patient outcomes and healthcare systems?</title>
         <author></author>
         <link>https://padlet.com/CarolynKelley/mqro75rxkpnxq68u/wish/3297685754</link>
         <description><![CDATA[<p>Predicting hospital readmission for heart failure patients is crucial both for enhancing patient outcomes and improving the efficiency of healthcare systems. The ability to forecast readmissions allows healthcare providers to implement timely interventions and optimize care plans for heart failure patients, addressing several significant aspects.</p><p>One of the primary advantages of predicting readmissions is the potential improvement in patient outcomes. When healthcare providers can identify patients at high risk for readmission, they can tailor follow-up care and interventions aimed at reducing this risk. Studies suggest that about 25% of patients with prior heart failure admissions are readmitted within 30 days, and these readmissions are often preventable through better management and follow-up care. More effective post-discharge strategies, such as medication reconciliation and patient education, can significantly reduce the likelihood of readmission, directly impacting patient recovery and health status. By predicting which patients are more likely to be readmitted, healthcare systems can implement preventative measures, potentially improving survival rates and quality of life for these patients.</p><p><br/></p><p>From a healthcare systems perspective, predicting hospital readmissions can lead to significant economic benefits. Hospital readmissions are a substantial source of healthcare costs. By utilizing predictive models to identify high-risk patients, hospitals can allocate resources more effectively, focusing on intensive management strategies for those most at risk of readmission.</p><p><br/></p><p>Moreover, studies have shown that employing machine learning and other predictive models can refine the accuracy of identifying patients who might be at risk of readmission, leading to reduced rates of unnecessary hospitalizations. This improved resource allocation not only aids in curtailing hospital costs but also enhances the quality of care delivered to patients, as healthcare providers can dedicate time and attention where it is genuinely needed.</p><p><br/></p><p>• What are the advantages and disadvantages of using data science (AI/ML) models compared to traditional biostatistics?</p><p>One of the most significant advantages of data science models is their ability to handle vast amounts of diverse data. Unlike traditional biostatistics, which often relies on structured datasets and specific statistical tests, data science can analyze both structured and unstructured data, such as images, text, and sensor data. This capability allows for a more holistic understanding of patient data and leads to richer insights.</p><p><br/></p><p>Moreover, data science models utilize advanced algorithms that can identify complex patterns and relationships within data that traditional methods might overlook. For example, machine learning models can learn from large datasets to make accurate predictions about patient outcomes or disease risks. This predictive capability enables healthcare providers to implement preemptive interventions, significantly enhancing patient care and outcomes.</p><p><br/></p><p>• How does the integration of AI into clinical workflows highlight the need for collaboration between data scientists, clinicians, and administrators?</p><p>The integration of AI into clinical workflows underscores the necessity for collaboration among data scientists, clinicians, and administrators by enhancing decision-making, addressing ethical challenges, and improving workflow efficiency. Data scientists develop algorithms that clinicians use for patient care, requiring feedback to ensure practicality and relevance. Additionally, administrators oversee the strategic implementation of AI in healthcare settings, focusing on resource allocation, and overall operational efficiency while ensuring compliance with regulatory standards and ethical considerations. This teamwork fosters innovation and optimizes patient outcomes, highlighting the interconnected nature of their roles in healthcare.</p><p>KATE T. TRAN</p>]]></description>
         <enclosure url="" />
         <pubDate>2025-01-20 17:43:02 UTC</pubDate>
         <guid>https://padlet.com/CarolynKelley/mqro75rxkpnxq68u/wish/3297685754</guid>
      </item>
      <item>
         <title>Clinicians, data scientists, and administrators</title>
         <author></author>
         <link>https://padlet.com/CarolynKelley/mqro75rxkpnxq68u/wish/3299673974</link>
         <description><![CDATA[<p>Each of these groups is essential to providing a well-formed product for any machine learning or AI to be practically used in the clinic. Often, physicians have traditions and shortcuts developed through training and medical school to help them understand and evaluate patients. Due to the vastness of the information they are required to know about every condition within their specialty, it can be difficult to introduce something new, such as AI, that would require months of training to understand the most basic principles. That is why data scientists need to help develop frameworks and tools to assist clinicians in designing AI or ML tools to look similar or use the same information they are used to so that the novelty of ML and AI can not be overshadowed by the new statistical terminology and formatting that data scientist is used to reporting. Lastly, the data given to data scientists often are a product of a hospital-wide or database-wide program that administrators control. Suppose administrators are included in discussing what data scientists need to develop clinician-friendly interfaces. In that case, then steps such as data quality analysis and harmonization can be streamlined within the system, require less work from the entire team to analyze, and reduce the introduction of bias from the raw data.</p><p>-Madison Farnsworth</p>]]></description>
         <enclosure url="" />
         <pubDate>2025-01-22 02:42:35 UTC</pubDate>
         <guid>https://padlet.com/CarolynKelley/mqro75rxkpnxq68u/wish/3299673974</guid>
      </item>
      <item>
         <title>Module 1 - Responses</title>
         <author></author>
         <link>https://padlet.com/CarolynKelley/mqro75rxkpnxq68u/wish/3302278338</link>
         <description><![CDATA[<ol><li><p>Predicting hospital readmission is important on both a micro and macroscale. On a microscale, the prediction helps to identify those patients who are vulnerable or are at an increased risk of hospital readmission which would lead to the development and implementation of appropriate interventions to reduce their risk. The end result being that further care and attention (in the form of telehealth consultations and increased medical adherence) would improve patient health outcomes and, down the road, reduce burdens for both patients and their families.</p><p>On a macroscale, readmissions are a large economic burden on the healthcare system- not only financially, but resource- and staffing-wise. If hospitals can predict hospital readmission for heart failure patients, this would allow resources to be allocated to another area of concern.</p><p><br/></p></li><li><p>From my understanding, biostatistics is a foundation from which data science (AI/ML) models are built upon. Data science models, however, take it a step further, in that they can be used to create more granular and accurate information. Compared to traditional biostatistics, AI/ML models improve patient outcomes through personalized treatment and continuous monitoring (ex. use of wearable devices) to track data in real-time and enable appropriate intervention in a timely manner, as needed. The information captured from these models can also be used in predictive analytics to understand future health trends and patient outcomes, therefore contributing to public health initiatives and long-term planning. When applied correctly, the information from AI/ML models can reduce economic burden in healthcare systems and promote adequate resource allocation to address other areas of concern for more efficient and effective workflows. Another advantage of these data science models is that they can analyze large unstructured healthcare data to develop meaningful interpretations and insights.</p><p>While analyzing large amounts of healthcare data is an advantage, it is also a disadvantage. The data being analyzed may come from a variety of sources or organizations. Therefore, the data may not be uniformed throughout as agencies have their own method for data collection or coding or may have specific data standards. Consolidating and cleaning the healthcare data, in of itself, can pose challenges and complexities. Additionally, with the advent of ever-changing technology and the implementation of AI/ML models, ensuring confidentiality and security are even more of a concern. The question that arises when using AI/ML is, how do we maximize its use in the healthcare data realm while still ensuring that patient privacy and confidentiality, as well as other ethical considerations, are respected and upheld?</p><p><br/></p></li><li><p>Every data scientist, clinician and administrator has a particular skillset and knowledge-base that the other professional does not have. The clinician would be able to bring their clinical expertise to a project having an understanding of clinical data, such as biological or chemical processes, natural progression of the disease of interest, or even patient outcomes. An administrator, on the other hand, would have access to administrative data, including an understanding of billing and insurance or hospital readmissions. Furthermore, these professionals would be helpful in providing demographic data needed to include in an analysis of healthcare data. Lastly, data scientists would contribute their skills in analyzing the data, selecting the most appropriate statistical test(s) or model(s) and assisting in data interpretation. The integration of AI into clinical workflows illustrates the importance of collaboration towards a common goal. Healthcare projects, such as those to improve patient quality of care, develop public health initiatives, reduce hospital readmission rates, and predict future health trends, are not siloed in nature. Professionals from various disciplines are needed to ensure that the information for such data science projects accurately reflect the different parts that contribute the issue.</p></li></ol><p>~Briana Lettsome</p>]]></description>
         <enclosure url="" />
         <pubDate>2025-01-23 18:12:05 UTC</pubDate>
         <guid>https://padlet.com/CarolynKelley/mqro75rxkpnxq68u/wish/3302278338</guid>
      </item>
      <item>
         <title>Questions</title>
         <author></author>
         <link>https://padlet.com/CarolynKelley/mqro75rxkpnxq68u/wish/3302501893</link>
         <description><![CDATA[<p>1.)&nbsp;The ability to predict hospital readmission for heart failure patients gives clinicians insight to preexisting conditions/lifestyle/demographic etc. factors which may influence a hospital readmission. In this way clinicians can identify risk factors of hospital readmission and take the necessary precautions to mitigate them.</p><p>2.)&nbsp;Pros of using traditional biostatistics are that it is a quick and self-explanatory way of obtaining simple answers and we understand exactly why the answer makes sense. If the data sets are small and I know what pattern I am measuring it is much more efficient to use traditional biostatistics. The cons of traditional biostatistics struggle with scalability and can require preprocessing and reduced data dimensions to handle large datasets in this way. It also limits the ability to look for new patterns as its measuring trends we already know to look for. The Pros of using AI/ML is that it handles larger datasets much faster and can identify novel patterns in the data, even if we were not looking for those patterns exactly. However, AI/ML limits our ability to see exactly how the answer was obtained (black-box) and also with the wrong instructions it also can give the wrong answers. There is also the idea that these models cannot use large health datasets that have missing data so filling in large sets of missing data is not accurate to patient record causes its own problems.</p><p>3.)&nbsp;Since clinical science is inherently multidimensional and interdisciplinary effective integration of AI/ML needs to be a collaboration between data scientists (develop train and validate AI/ML models), clinicians (provide expertise to ensure models are clinically valid) and administrators (are sure AI tools are feasible for cost compliance and integration into hospital systems) so that we can more effectively utilize AI/ML to cover all aspects of patient healthcare and accurately predict healthcare outcomes. Such collaboration ensures that all aspects of patient care are considered, and models are clinically relevant.</p><p>Katherine Araya</p>]]></description>
         <enclosure url="" />
         <pubDate>2025-01-23 22:02:55 UTC</pubDate>
         <guid>https://padlet.com/CarolynKelley/mqro75rxkpnxq68u/wish/3302501893</guid>
      </item>
      <item>
         <title>Heart Failure Patients Assignment</title>
         <author></author>
         <link>https://padlet.com/CarolynKelley/mqro75rxkpnxq68u/wish/3302861478</link>
         <description><![CDATA[<p>Predicting hospital readmissions for heart failure is important because it helps both patients and the healthcare system. When patients come back to the hospital, it usually means their health wasn’t managed well after they were discharged. This can lead to worse health and higher costs for the hospital. If we can predict who might be readmitted, doctors can provide better follow-up care to prevent it, improving health and saving resources.</p><p><br/></p><p>Using AI and machine learning has its pros and cons. AI can find patterns in large amounts of data and make very accurate predictions. But it’s often hard to understand how it works, which can make doctors hesitant to trust it. Traditional methods like biostatistics are simpler and easier to explain, but they can miss more complex patterns. Each method has its strengths depending on the situation.</p><p><br/></p><p>Bringing AI into healthcare works best when data scientists, doctors, and administrators work together. Data scientists build the tools, doctors make sure they actually help patients, and administrators ensure everything runs smoothly. Without teamwork, AI might not fit well into real hospital workflows or meet the needs of patients and staff.</p>]]></description>
         <enclosure url="" />
         <pubDate>2025-01-24 05:25:57 UTC</pubDate>
         <guid>https://padlet.com/CarolynKelley/mqro75rxkpnxq68u/wish/3302861478</guid>
      </item>
      <item>
         <title>Hospital readmission</title>
         <author></author>
         <link>https://padlet.com/CarolynKelley/mqro75rxkpnxq68u/wish/3302865737</link>
         <description><![CDATA[<p>Predicting hospital readmissions for heart failure patients is really important because it can improve care for patients and help hospitals run better. If a patient has to come back soon after being discharged, it usually means something went wrong—maybe they didn’t get the right follow-up care or their condition wasn’t fully under control. This isn’t just bad for their health, but it’s also expensive for hospitals. By predicting who might come back, doctors can step in early and give those patients extra care to keep them healthier and out of the hospital.</p><p><br/></p><p>AI and machine learning are powerful tools for this because they can work with lots of data and find patterns that aren’t obvious. This often makes their predictions very accurate. The downside is that these tools can be hard to understand, so doctors might not feel comfortable trusting them. Traditional methods, like biostatistics, are simpler and easier to explain, but they don’t always work well with large or messy data. Both have their place, depending on what you need.</p><p><br/></p><p>For AI to work well in healthcare, it takes teamwork. Data scientists build the models, but they need input from doctors to make sure the tools actually help in real-life care. Administrators also need to be involved to handle budgets, rules, and making sure the tools can be used smoothly. Without this collaboration, even the best AI tools might not fit into daily hospital life or give the best results for patients.</p><p><br/></p><ul><li><p>Anayansi Ramirez</p></li></ul>]]></description>
         <enclosure url="" />
         <pubDate>2025-01-24 05:31:52 UTC</pubDate>
         <guid>https://padlet.com/CarolynKelley/mqro75rxkpnxq68u/wish/3302865737</guid>
      </item>
      <item>
         <title>How does the integration of AI into clinical workflows highlight the need for collaboration between data scientists, clinicians, and administrators?</title>
         <author></author>
         <link>https://padlet.com/CarolynKelley/mqro75rxkpnxq68u/wish/3303213625</link>
         <description><![CDATA[<p>As many have already mentioned in the forum, implementation and integration into a health care system takes a multidisciplinary team and collaboration between all members. The data scientist will assist in creating the model. Clinicians will inform the clinical practice and consult on the identified patients. Administrators are needed to actually integrate it in the EHR system, help to flag patients who have been identified. It really takes a village.</p><p><br/></p><p>Yun-Yun Kathy Chen</p>]]></description>
         <enclosure url="" />
         <pubDate>2025-01-24 12:21:55 UTC</pubDate>
         <guid>https://padlet.com/CarolynKelley/mqro75rxkpnxq68u/wish/3303213625</guid>
      </item>
      <item>
         <title>For the first question, predicting probability of readmissions can save lives and save costs for hospital and the US health system.  In addition, health systems and health agencies can also target on particular subgroups if a particular group has a high probability for readmission. </title>
         <author></author>
         <link>https://padlet.com/CarolynKelley/mqro75rxkpnxq68u/wish/3303836165</link>
         <description><![CDATA[<p>For the second question, AI/ML can be applied to large datasets than traditional biostatistics tools. However, coding can be a bit complicated than traditional biostatistics tools. </p><p>For the third question, AI/ML allows the model to incorporate much more variables than a traditional biostatistics model.  Therefore, the models established by AI/ML need a multi-disciplinary team to help decide which variables are important in real life scenarios, and how to use the knowledge gained to improve general health.</p><p><br/></p><p>Yu Liu</p>]]></description>
         <enclosure url="" />
         <pubDate>2025-01-25 00:16:02 UTC</pubDate>
         <guid>https://padlet.com/CarolynKelley/mqro75rxkpnxq68u/wish/3303836165</guid>
      </item>
      <item>
         <title>Question Response</title>
         <author></author>
         <link>https://padlet.com/CarolynKelley/mqro75rxkpnxq68u/wish/3306003303</link>
         <description><![CDATA[<ol><li><p>Predicting hospital readmissions is important not only for heat failure patients, but all patients due to Medicare reimbursement. Hospitals lose money if patients are readmitted within that 30 day window. That lost reimbursement is then felt in the hospital in other places, such as nurses. </p></li><li><p>AI/ML models are significantly faster, and can handle more data at once. However if the data is incomplete or biased, AI/ML doesn't account for that and the results could be misleading. </p></li><li><p>Clinicians, like nurses and physicians need to be at the forefront of integrating AI/ML as they are the ones that can provide invaluable insight into the workflow and how it would actually work. They can provide feedback and input on necessary/unnecessary steps or information. </p></li></ol><p><br/></p><p>Bridget Webb </p>]]></description>
         <enclosure url="" />
         <pubDate>2025-01-27 17:45:20 UTC</pubDate>
         <guid>https://padlet.com/CarolynKelley/mqro75rxkpnxq68u/wish/3306003303</guid>
      </item>
      <item>
         <title>AI application, readmission Rate, and Health Failure expenses </title>
         <author></author>
         <link>https://padlet.com/CarolynKelley/mqro75rxkpnxq68u/wish/3306332053</link>
         <description><![CDATA[<p>Predicting hospital readmission for heart failure patients serves as a key clinical indicator of recovery and plays a crucial role in reducing healthcare costs. It enables early detection of high-risk individuals, allowing for targeted interventions such as medication changes, lifestyle advice, and follow-up care, ultimately preventing readmissions and improving both quality of life and patient health outcomes.</p><p>AI/ML models excel at identifying complex, nonlinear patterns in large datasets, which enhances prediction accuracy and enables more personalized treatment. However, they often require large datasets and can be challenging to interpret. In contrast, traditional biostatistics provides simpler, more understandable models, but may not capture the complex relationships within the data, limiting predictive capabilities.</p><p>Integrating AI into clinical workflows highlights the importance of collaboration between data scientists, clinicians, and administrators. Data scientists bring their technical expertise in developing predictive models, clinicians ensure the models are aligned with relevant clinical outcomes, and administrators help implement the results within healthcare systems.</p><p>Ali Salman</p>]]></description>
         <enclosure url="" />
         <pubDate>2025-01-27 23:14:32 UTC</pubDate>
         <guid>https://padlet.com/CarolynKelley/mqro75rxkpnxq68u/wish/3306332053</guid>
      </item>
      <item>
         <title>AI/ML in healthcare</title>
         <author></author>
         <link>https://padlet.com/CarolynKelley/mqro75rxkpnxq68u/wish/3308550855</link>
         <description><![CDATA[<p>1.&nbsp;&nbsp;&nbsp;&nbsp; Predicting readmissions can help allocate resources more efficiently. If an intervention was implemented for all patients, it would be much more costly than implementing an intervention only for a portion of the population most at risk of readmission.</p><p>2.&nbsp;&nbsp;&nbsp;&nbsp; One big advantage is that the features important for a predictive model can be chosen by the AI/ML model rather than known ahead of time. This decreases the likelihood of investigator bias affecting the results. A disadvantage is that the source and quality of the data need to be scrutinized to avoid introducing inadvertent bias into the algorithm.</p><p>3.&nbsp;&nbsp;&nbsp;&nbsp; All of these specialties will be involved in implementing any improvements identified by AI. Clinicians need to be involved to make sure appropriate data are being analyzed, that the patient population is representative, and that any implementation of an intervention is appropriate. Data scientists need to make sure the data is of high quality, confounders/biases are addressed, and statistical models are used correctly, administrators need to make sure that resources are allocated efficiently and equitably.</p><p>Kelly DuBois</p>]]></description>
         <enclosure url="" />
         <pubDate>2025-01-29 15:06:10 UTC</pubDate>
         <guid>https://padlet.com/CarolynKelley/mqro75rxkpnxq68u/wish/3308550855</guid>
      </item>
      <item>
         <title>Q1 Q2 Q3</title>
         <author></author>
         <link>https://padlet.com/CarolynKelley/mqro75rxkpnxq68u/wish/3308680683</link>
         <description><![CDATA[<p>Predicting readmissions allows healthcare providers to identify high-risk individuals and implement targeted interventions to prevent unnecessary hospitalizations. This ultimately reduces patient costs and alleviates the burden on the hospital system. Proactive management enhances care coordination and follow-up, enabling adjustments in medication plans and self-monitoring strategies. The use of wearable monitoring devices may further support these efforts. Additionally, improving performance metrics can enhance predictive models, helping to identify the most vulnerable patients and reduce mortality rates.  </p><p>ML focuses on making accurate predictions, while traditional statistical models aim to infer relationships between variables. ML is more flexible and scalable, making it useful for tasks like diagnosis, classification, and survival prediction. Traditional methods work better when prior knowledge is strong, the number of cases is much higher than the number of variables, and findings need to be interpretable, such as in public health. ML excels in data-heavy fields like omics, radiodiagnostics, and drug development. Combining both approaches is often the best strategy. AI, by processing large datasets from multiple sources, can enhance prediction and decision-making in healthcare.   </p><p>AI is transforming healthcare by addressing rising costs, limited access, and the demand for personalized care. Though not new, its ability to learn and improve makes it invaluable for diagnosis and prediction. AI enhances patient flow, reduces wait times, and improves efficiency in hospitals. Future advancements may include real-time scheduling, deeper integration with electronic health records, and predictive analytics for better resource allocation. </p><p>Aleksandra Leszczynska</p>]]></description>
         <enclosure url="" />
         <pubDate>2025-01-29 16:37:58 UTC</pubDate>
         <guid>https://padlet.com/CarolynKelley/mqro75rxkpnxq68u/wish/3308680683</guid>
      </item>
      <item>
         <title></title>
         <author></author>
         <link>https://padlet.com/CarolynKelley/mqro75rxkpnxq68u/wish/3308889150</link>
         <description><![CDATA[<p>Predicting hospital readmission for heart failure patients is important because it helps improve patient care and reduces healthcare costs. Catching high-risk patients early means doctors can step in with better treatment, prevent complications, and keep people healthier. It also helps hospitals save money and avoid penalties for excessive readmissions. Plus, it ensures beds are available for those who need them most. With good predictions, hospitals can plan better follow-ups, educate patients on managing their condition, and keep more people out of the hospital in the first place.</p><p><br/></p><p>AI/ML models have the advantage of detecting complex patterns that traditional biostatistics might miss, often leading to more accurate predictions. They can process massive datasets, including images and text, and continuously learn and improve over time. However, they come with challenges, such as being difficult to interpret (the black box problem), requiring large amounts of data, and sometimes overfitting by finding patterns that aren’t actually meaningful. AI/ML also demands significant computing power and isn't always widely accepted in regulated healthcare settings. On the other hand, traditional biostatistics is excellent for understanding cause-and-effect relationships and providing interpretable results. The best approach? Likely a mix of both, combining AI’s predictive power with the clarity of biostatistics.</p><p><br/></p><p>Integrating AI into clinical workflows isn’t just about plugging in a model and expecting better outcomes—it requires teamwork. Data scientists build and refine AI models, but without input from clinicians, those models might not align with real-world medical decision-making. Clinicians bring essential domain expertise, ensuring AI recommendations make sense in practice and improving trust in the technology. Meanwhile, administrators play a key role in managing resources, compliance, and implementation, making sure AI tools fit within existing hospital systems and regulations. Without collaboration, AI risks being either too complex to use, misaligned with clinical needs, or stuck in bureaucratic limbo. Effective teamwork ensures AI enhances patient care rather than adding extra complexity.</p><p><br/></p><p>Murad Moqbel</p>]]></description>
         <enclosure url="" />
         <pubDate>2025-01-29 19:09:00 UTC</pubDate>
         <guid>https://padlet.com/CarolynKelley/mqro75rxkpnxq68u/wish/3308889150</guid>
      </item>
      <item>
         <title></title>
         <author></author>
         <link>https://padlet.com/CarolynKelley/mqro75rxkpnxq68u/wish/3310203261</link>
         <description><![CDATA[<p>Predicting readmission for HF is important for early intervention and to prevent later heath issues. By addressing signs of HF earlier in the process these interventions can reduce strain on the healthcare system and more importantly, decrease the patient's likelihood of readmission and complications. While one advantages of the use of AI in this context is its ability to find nuanced trends and patterns across various patient records that clinicians don't have the processing power for, you do lose explainability and interpretability which is essential in the healthcare field. Traditional biostatistics approaches are more interpretable via significance testing and how regression produced compared to AI and ML models that utilize neural networks which produce weights and a black box approach. With this integration of AI in healthcare, it necessitates collaboration across various domains because of the varying expertise that can cover concerns around explainability, data privacy, variable selection, and the centering of the need of the patients, which each collaborator brings a different but useful understanding of. </p><p><br/></p><p>Christina Chance</p>]]></description>
         <enclosure url="" />
         <pubDate>2025-01-30 18:26:25 UTC</pubDate>
         <guid>https://padlet.com/CarolynKelley/mqro75rxkpnxq68u/wish/3310203261</guid>
      </item>
      <item>
         <title>Predicting Hospital Readmission for Heart Failure Patients</title>
         <author></author>
         <link>https://padlet.com/CarolynKelley/mqro75rxkpnxq68u/wish/3310325408</link>
         <description><![CDATA[<p>Predicting hospital readmission for heart failure patients is crucial for both patient outcomes and healthcare systems. High readmission rates indicate potential gaps in patient care, leading to worsened health conditions, increased mortality risk, and higher healthcare costs. By leveraging predictive models, hospitals can identify at-risk patients early, implement targeted interventions, and improve overall patient management. </p><p>AI/ML models offer several advantages over traditional biostatistical approaches. Machine learning can uncover complex, non-linear relationships within large datasets, enabling higher predictive accuracy and adaptability.</p><p>The integration of AI into clinical workflows underscores the importance of collaboration between data scientists, clinicians, and administrators. Data scientists ensure the technical robustness of AI models, while clinicians provide domain expertise to validate model outputs and ensure clinical relevance</p>]]></description>
         <enclosure url="" />
         <pubDate>2025-01-30 20:14:44 UTC</pubDate>
         <guid>https://padlet.com/CarolynKelley/mqro75rxkpnxq68u/wish/3310325408</guid>
      </item>
      <item>
         <title>&#39;predicting hospital readmission for heart failure patients&#39;</title>
         <author></author>
         <link>https://padlet.com/CarolynKelley/mqro75rxkpnxq68u/wish/3312224764</link>
         <description><![CDATA[<p><strong>Predicting hospital readmission for heart failure patients</strong> is crucial because it helps identify patients at high risk of returning to the hospital, allowing healthcare providers to intervene early with appropriate treatments and support. This can improve patient outcomes by reducing complications and mortality rates and also decrease healthcare costs by preventing unnecessary readmissions.</p><p><strong>Advantages of using AI/ML models</strong> over traditional biostatistics include the ability to analyze large datasets quickly and accurately, identify complex patterns and interactions, and provide personalized predictions. However, disadvantages include the need for extensive training data, potential biases in the data, and the "black box" nature of some AI models, which can make it difficult to understand how they arrive at their predictions.</p><p><strong>Integration of AI into clinical workflows</strong> highlights the need for collaboration between data scientists, clinicians, and administrators. Data scientists develop and refine AI models, clinicians provide clinical insights and validate the models, and administrators ensure the integration aligns with hospital policies and workflows. This collaboration ensures that AI tools are effective, accurate, and seamlessly integrated into patient care.</p><p><br/></p><p>Farzana Hussain</p>]]></description>
         <enclosure url="" />
         <pubDate>2025-02-01 23:56:19 UTC</pubDate>
         <guid>https://padlet.com/CarolynKelley/mqro75rxkpnxq68u/wish/3312224764</guid>
      </item>
      <item>
         <title>AI and Biostatistics in Heart Failure Predictions &amp; Clinical Integration</title>
         <author></author>
         <link>https://padlet.com/CarolynKelley/mqro75rxkpnxq68u/wish/3312250085</link>
         <description><![CDATA[<p><em>1.	Why is predicting hospital readmission for heart failure patients important for patient outcomes and healthcare systems?</em></p><p>Predicting hospital readmission for heart failure patients allows for timely identification that prompts early intervention and targeted care management. It could also help healthcare systems reduce costs and avoid financial penalties associated with high readmission rates.</p><p><br/></p><p><em>2.	What are the advantages and disadvantages of using data science (AI/ML) models compared to traditional biostatistics?</em></p><p>Data science models offer greater flexibility in handling diverse data types (structured, unstructured, and real-time) and excel at automation and predictive tasks across multiple industries, making them particularly powerful for complex pattern recognition and large-scale data analysis. However, these advantages come with trade-offs when compared to traditional biostatistical approaches, which provide stronger statistical inference and hypothesis testing capabilities that are crucial for clinical trials and medical research. While data science methods like machine learning can handle more complex scenarios and offer broader applications from disease outbreaks to staffing optimization, traditional biostatistical methods remain superior for rigorous statistical validation and are more interpretable in healthcare settings where understanding the underlying relationships between variables is crucial.</p><p><br/></p><p><em>3.	How does the integration of AI into clinical workflows highlight the need for collaboration between data scientists, clinicians, and administrators?</em></p><p>As data scientists bring essential capabilities in processing large datasets, designing algorithms, and developing machine learning models, while clinicians provide crucial medical domain knowledge and ensure AI tools align with patient care objectives, this interdisciplinary collaboration work together to produce comprehensive tools that improve patient outcomes.</p><p><br/></p><ul><li><p>Olabisi Ojo</p></li></ul><p><br/></p>]]></description>
         <enclosure url="" />
         <pubDate>2025-02-02 01:57:34 UTC</pubDate>
         <guid>https://padlet.com/CarolynKelley/mqro75rxkpnxq68u/wish/3312250085</guid>
      </item>
      <item>
         <title>The importance of interdisciplinary teamwork when using AI/ML to reduce costs and improve patient outcomes by predicting heart failure hospital readmissions</title>
         <author></author>
         <link>https://padlet.com/CarolynKelley/mqro75rxkpnxq68u/wish/3314240802</link>
         <description><![CDATA[<p>Heart failure is a leading cause of hospital readmissions, which contribute to increased healthcare costs as well as adverse patient outcomes. While AI/ML models can help accurately risk stratify patients so that those patients identified as high risk can receive additional care, it is important to ensure proper implementation of such technologies as they are also associated with disadvantages like statistical misinterpretations, biases and ethical concerns. An important way to mitigate such issues is to build interdisciplinary teams when integrating AI into clinical workflows, where data scientists, clinicians and administrators work in close collaboration.</p><p><br/></p><p>Veronica Wallaengen</p>]]></description>
         <enclosure url="" />
         <pubDate>2025-02-03 20:35:57 UTC</pubDate>
         <guid>https://padlet.com/CarolynKelley/mqro75rxkpnxq68u/wish/3314240802</guid>
      </item>
      <item>
         <title></title>
         <author></author>
         <link>https://padlet.com/CarolynKelley/mqro75rxkpnxq68u/wish/3315909541</link>
         <description><![CDATA[<ol><li><p>Predicting hospital readmission for heart failure patients is crucial for improving patient outcomes and reducing healthcare costs. Early identification of high-risk patients allows for targeted interventions, such as medication adjustments and follow-up care, to prevent complications. This reduces hospital overcrowding, improves resource allocation, and enhances quality of care.</p></li></ol><p><br/></p><ol start="2"><li><p>Advantages: AI/ML models can handle large, complex datasets, uncover hidden patterns, and improve predictive accuracy. They adapt to new data more effectively than traditional methods.</p><p><br/></p><p>Disadvantages: AI/ML models require large, high-quality datasets, can be opaque ("black box"), and may introduce bias if not trained on representative data. Traditional biostatistics provides interpretable results but may struggle with nonlinear relationships.</p></li></ol><p><br/></p><ol start="3"><li><p>Integrating AI into clinical workflows requires collaboration between data scientists, clinicians, and administrators. Clinicians ensure models align with medical knowledge, administrators support implementation, and data scientists refine algorithms. This teamwork enhances model trust, usability, and ethical considerations, ensuring AI tools improve patient care rather than disrupt clinical decision-making.</p></li></ol>]]></description>
         <enclosure url="" />
         <pubDate>2025-02-04 20:29:02 UTC</pubDate>
         <guid>https://padlet.com/CarolynKelley/mqro75rxkpnxq68u/wish/3315909541</guid>
      </item>
      <item>
         <title>Heart failure predictoin</title>
         <author></author>
         <link>https://padlet.com/CarolynKelley/mqro75rxkpnxq68u/wish/3317872158</link>
         <description><![CDATA[<p>It is important to estimate heart failure patients' readmission rate because controlling readmissoin can reduce healthcare cost and improve quality.  Understanding the readmission rate can also help healthcare workers to target specific population to provide intervention.  The advantage is ML/AI can analyze large dataset and can establish complicated models.  The disadvantage of ML/AI is it is complicated.  The workflow of AI needs multi-disceiplinary team becaus the complicated of healthcare data and needs input from different stakeholders like administrative support and medical insights.</p><p>Yu Liu</p>]]></description>
         <enclosure url="" />
         <pubDate>2025-02-06 02:51:38 UTC</pubDate>
         <guid>https://padlet.com/CarolynKelley/mqro75rxkpnxq68u/wish/3317872158</guid>
      </item>
      <item>
         <title>Module 1 response</title>
         <author></author>
         <link>https://padlet.com/CarolynKelley/mqro75rxkpnxq68u/wish/3318023353</link>
         <description><![CDATA[<p>Predicting hospital readmission for heart failure patients is crucial for improving patient outcomes and reducing healthcare costs, as early identification of high-risk patients allows for timely intervention and resource allocation. While traditional biostatistical models are well-established in clinical research, AI and machine learning (ML) models offer advantages like handling large, complex datasets and potentially improving predictive accuracy. However, AI/ML models also come with challenges. The need for large, high-quality datasets and potential biases are just a few examples that can impact clinical decision-making and trust. Integrating AI into clinical workflows underscores the importance of collaboration between data scientists, clinicians, and administrators to ensure that models are not only technically robust but also clinically relevant, ethically sound, and seamlessly integrated into our hospital systems.</p><p><br/></p><p>Ryan K. Perez</p>]]></description>
         <enclosure url="" />
         <pubDate>2025-02-06 05:44:11 UTC</pubDate>
         <guid>https://padlet.com/CarolynKelley/mqro75rxkpnxq68u/wish/3318023353</guid>
      </item>
      <item>
         <title>Meaningful use of AI in clinical settings</title>
         <author></author>
         <link>https://padlet.com/CarolynKelley/mqro75rxkpnxq68u/wish/3319261882</link>
         <description><![CDATA[<p>Healthcare providers and organizations need to predict the burden of hospital readmission due to heart failure, because preventable readmissions account for a large proportion of resources utilization which could have been used for serving other patients or saving more lives. In addition, reduced readmission can be an indicator of improved post-discharge outcomes and adherence to follow up care, which would improve health and quality of life in patients. Taken together, optimizing care and reducing readmission can be beneficial for patients and providers enhancing health outcomes and reducing costs of care in a population.</p><p><br/></p><p>AI offers several benefits over traditional statistics. Researchers can use AI to develop actionable perspectives using large bodies of data resources, which can be problematic to analyze using traditional approaches. Moreover, AI can offer diverse resources that may help researchers and clinicians understand the patterns or possible interpretations of complex data, which may not be achievable in traditional statistical approaches. Lastly, AI can facilitate or augment human efforts in data analyses, minimizing the required time and labor for data management and analyses and promoting accuracy in the data deliverables. However, AI is an umbrella term and the use of specific AI models and resources need to be evaluated carefully, and it may not be reasonable to assume that AI will always be necessary or can replace the need for traditional biostatistics.</p><p><br/></p><p>Effective integration and utilization of AI would require collaborative efforts from data scientists, administrators, and healthcare providers, alongside other professionals. Many of them would bring insights on how and why AI is relevant to clinical decision-making, whereas some of them would provide actionable strategies for using AI in improving health outcomes in real-world settings.</p><p><br/></p><p>Given the rapid evolution of AI in all industries, including healthcare, exchanging knowledge and skills on AI applications and applying the same in advancing clinical care would take a village instead of isolated measures. Moreover, continued assessment of ethical concerns and appropriateness of AI tools and resources in diverse healthcare operations are critical. Therefore, professionals with varying skills and experiences need to work together to harmonized the use of AI in medicine and ensure equitable applications of AI technologies in clinical research and practice.</p><p><br/></p><p>M. Mahbub Hossain</p>]]></description>
         <enclosure url="" />
         <pubDate>2025-02-07 00:44:15 UTC</pubDate>
         <guid>https://padlet.com/CarolynKelley/mqro75rxkpnxq68u/wish/3319261882</guid>
      </item>
      <item>
         <title>Why is predicting hospital readmission for heart failure patients important for patient outcomes and healthcare systems?</title>
         <author></author>
         <link>https://padlet.com/CarolynKelley/mqro75rxkpnxq68u/wish/3321126247</link>
         <description><![CDATA[<p>It aids in proactive interventions and helps to decrease hospital readmission rate so as to save health system expenditure.</p><p><br/></p><p>Mian Pan</p>]]></description>
         <enclosure url="" />
         <pubDate>2025-02-09 04:06:51 UTC</pubDate>
         <guid>https://padlet.com/CarolynKelley/mqro75rxkpnxq68u/wish/3321126247</guid>
      </item>
      <item>
         <title>What are the advantages and disadvantages of using data science (AI/ML) models compared to traditional biostatistics?</title>
         <author></author>
         <link>https://padlet.com/CarolynKelley/mqro75rxkpnxq68u/wish/3321127140</link>
         <description><![CDATA[<p>Advantages: mostly better on accuracy, efficiency.</p><p>Disadvantages: AL/ML also poses issues including bias, privacy, ethical considerations, etc.</p><p><br/></p><p>Mian Pan</p>]]></description>
         <enclosure url="" />
         <pubDate>2025-02-09 04:11:07 UTC</pubDate>
         <guid>https://padlet.com/CarolynKelley/mqro75rxkpnxq68u/wish/3321127140</guid>
      </item>
      <item>
         <title>How does the integration of AI into clinical workflows highlight the need for collaboration between data scientists, clinicians, and administrators?</title>
         <author></author>
         <link>https://padlet.com/CarolynKelley/mqro75rxkpnxq68u/wish/3321130588</link>
         <description><![CDATA[<p>Clinical workflows equipped with AI involves multidisciplinary team including data scientists, clinicians, and administrators each of which specialize in a different area which make it extremely important for effective collaboration between each part.</p><p><br/></p><p>Mian Pan   </p>]]></description>
         <enclosure url="" />
         <pubDate>2025-02-09 04:25:37 UTC</pubDate>
         <guid>https://padlet.com/CarolynKelley/mqro75rxkpnxq68u/wish/3321130588</guid>
      </item>
      <item>
         <title>Module 1</title>
         <author></author>
         <link>https://padlet.com/CarolynKelley/mqro75rxkpnxq68u/wish/3321144755</link>
         <description><![CDATA[<p>Why is predicting hospital readmission for heart failure patients important for patient outcomes and healthcare systems?</p><ul><li><p>Predicting hospital readmission for heart failure patients is important because practitioners were able to identify the patients most at-risk of readmissions and provide additional in-home treatments that were preventative and improved patient overall outcome and reduced healthcare cost to the patient as well as the hospitals.</p></li></ul><p>What are the advantages and disadvantages of using data science (AI/ML) models compared to traditional biostatistics?</p><ul><li><p>AI/ML models can leverage large data to quickly to aid in timely diagnosis and that can advance medical innovation and improve patient health outcomes. However, the researcher's statistical knowledge is paramount in the accurate interpretation of the results, security protocols that adheres to HIPAA and GDPR are needed, and the ethical deployment of AI/ML algorithms are all important yet remains to be a challenge in the use of AI/ML.</p></li></ul><p><br/></p><p>How does the integration of AI into clinical workflows highlight the need for collaboration between data scientists, clinicians, and administrators?</p><p><br/></p><p>AI utilizes human intelligence to create models that solves problem. While data scientists are needed to conduct the technical aspects of integration of AI into clinical workflows, there is a great need of clinicians to provide the necessary "intelligence" and specific content for the model and implement the new discovery in the practice setting for improved health outcomes of patients. Finally, the administrators are necessary to ensure the integration of AI in clinical and research settings meets federal regulations and is ethical.</p><p><br/></p><p>Scherrayn Phillip-Garcia</p>]]></description>
         <enclosure url="" />
         <pubDate>2025-02-09 05:20:34 UTC</pubDate>
         <guid>https://padlet.com/CarolynKelley/mqro75rxkpnxq68u/wish/3321144755</guid>
      </item>
      <item>
         <title>What are the advantages and disadvantages of using data science (AI/ML) models compared to traditional biostatistics?</title>
         <author></author>
         <link>https://padlet.com/CarolynKelley/mqro75rxkpnxq68u/wish/3321646196</link>
         <description><![CDATA[<p>One of the biggest problems is the data representation. An AI model can only show insights about the data that is included and unfortunately, data for some groups are not wholly included. Therefore the model becomes biased not because of the programmer/developer but because there isn't a true sense of what happens among those affected. </p><p><br/></p><p>Loni Taylor</p>]]></description>
         <enclosure url="" />
         <pubDate>2025-02-09 22:09:34 UTC</pubDate>
         <guid>https://padlet.com/CarolynKelley/mqro75rxkpnxq68u/wish/3321646196</guid>
      </item>
      <item>
         <title>Heart Failure Activity</title>
         <author></author>
         <link>https://padlet.com/CarolynKelley/mqro75rxkpnxq68u/wish/3321988992</link>
         <description><![CDATA[<p>One reason why predicting hospital readmissions is important for heart failure patients is because it can predict the quality of treatments or services. For example, if a patient was hospitalized for 2 weeks on an IV drug but was readmitted later, it could be because the drug was not effective in alleviating symptoms. Another reason why such a prediction is necessary is because it can encourage precautionary interventions such as medication adherence, as shown in the example, that prevent adverse outcomes and rising hospital costs due to staffing, diagnostic tests, equipment, medication, etc. Data science could be used for such predictions. The advantages of using data science models compared to traditional biostatistics includes that it can handle very large datasets for possible relationships between variables in multiple formats such as images, text and unstructured data. However, the disadvantages of AI/ML models include that they are “black boxes”, where the actual calculations that are run by the model can not be confirmed to validate the results as in a code using traditional biostatistics. In addition, since data can come in various formats and sources, it can be hard to integrate, which makes analysis difficult. Bias is also a very important factor as the data used to train a model needs to be representative of the patient population being considered, otherwise the testing accuracy can be skewed and result in critical errors that influence clinical decision-making and harm patients. However, the interdisciplinary nature of AI application in clinical workflows highlights the need for collaboration between data scientists, clinicians and administrators. For example, data scientists are needed to analyze the EHR data through pre-processing using imputation and train-test splits, develop models such as linear regression and evaluate their performance. In addition, clinicians are needed for clarifying the meaning of EHR variables and their connection to the problem that the team is working on as well as for developing interventions using the results of the AI model testing. Finally, administrators are needed to integrate AI into healthcare by allocating resources, such as materials, technology, staffing and funding, into the project as well as ensuring that the team follows HIPPA and General Data Protection Regulations (GDPR).</p><p><br/></p><p>(Asma Sodager)</p>]]></description>
         <enclosure url="" />
         <pubDate>2025-02-10 05:25:04 UTC</pubDate>
         <guid>https://padlet.com/CarolynKelley/mqro75rxkpnxq68u/wish/3321988992</guid>
      </item>
      <item>
         <title>a great example that showcase the benefits to both patients and healthcare systems.  The prediction enables early interventions and reduces complications and mortality.  The hospital leverages the data-driven decision making process and reduces hospital burden by 20% reduction in 30-days readmission rate, also saved $1M annually. </title>
         <author></author>
         <link>https://padlet.com/CarolynKelley/mqro75rxkpnxq68u/wish/3323542343</link>
         <description><![CDATA[]]></description>
         <enclosure url="" />
         <pubDate>2025-02-11 03:54:29 UTC</pubDate>
         <guid>https://padlet.com/CarolynKelley/mqro75rxkpnxq68u/wish/3323542343</guid>
      </item>
      <item>
         <title></title>
         <author></author>
         <link>https://padlet.com/CarolynKelley/mqro75rxkpnxq68u/wish/3326109158</link>
         <description><![CDATA[<p><strong>·&nbsp;Why is predicting hospital readmission for heart failure patients important for patient outcomes and healthcare systems?</strong></p><p>&nbsp;</p><p>Predicting hospital readmissions for heart failure patients enables timely interventions, such as ensuring medication adherence and providing additional care to high-risk individuals. This proactive approach can reduce 30-day readmission rates, leading to improved patient outcomes and healthcare cost savings. For instance, in the example, the prediction model was associated with a 20% reduction in readmission rates and an annual savings exceeding $1 million.</p><p>&nbsp;</p><p><strong>·&nbsp;What are the advantages and disadvantages of using data science (AI/ML) models compared to traditional biostatistics?</strong></p><p>&nbsp;</p><p>AI/ML models can handle complex, diverse datasets, including both structured and unstructured data, and can process large volumes of information in real-time. They often provide higher predictive accuracy through advanced techniques. However, these models can be less interpretable, require larger datasets, and may introduce biases if not properly managed. Traditional biostatistics offers more straightforward interpretability but may struggle with complex or large-scale data.</p><p>&nbsp;</p><p><strong>·&nbsp;How does the integration of AI into clinical workflows highlight the need for collaboration between data scientists, clinicians, and administrators?</strong></p><p>&nbsp;</p><p>Integrating AI into clinical workflows requires collaboration among data scientists, clinicians and administrators. Data scientists develop algorithms to analyze complex medical data, clinicians provide domain expertise to ensure the models are clinically relevant and effective, while administrators oversee implementation, ensure compliance, and evaluate the effectiveness of these models in reducing clinician workload and enhancing patient care. This multidisciplinary approach ensures effective and responsible integration of AI tools in healthcare.</p><p><br/></p><p>-Janette Vazquez</p>]]></description>
         <enclosure url="" />
         <pubDate>2025-02-12 16:55:02 UTC</pubDate>
         <guid>https://padlet.com/CarolynKelley/mqro75rxkpnxq68u/wish/3326109158</guid>
      </item>
      <item>
         <title>Why is predicting hospital readmission for heart failure patients important for patient outcomes and healthcare systems?</title>
         <author></author>
         <link>https://padlet.com/CarolynKelley/mqro75rxkpnxq68u/wish/3326187460</link>
         <description><![CDATA[<p>Predicting hospital readmissions is crucial because it gives us a chance to step in before things get worse. For patients, it’s about giving them the right care early on whether that’s managing symptoms better or adjusting their treatment plan. If we can identify who’s at risk, we can help prevent unnecessary readmissions, which ultimately leads to better health outcomes. For the healthcare system, this approach can save a lot of resources. Hospitals can focus on preventing avoidable readmissions, which means better use of time, lower costs, and higher patient satisfaction.</p><p>Sadaf Ghaderzadeh, PhD</p>]]></description>
         <enclosure url="" />
         <pubDate>2025-02-12 17:52:56 UTC</pubDate>
         <guid>https://padlet.com/CarolynKelley/mqro75rxkpnxq68u/wish/3326187460</guid>
      </item>
      <item>
         <title>What are the advantages and disadvantages of using data science (AI/ML) models compared to traditional biostatistics?</title>
         <author></author>
         <link>https://padlet.com/CarolynKelley/mqro75rxkpnxq68u/wish/3326214050</link>
         <description><![CDATA[<p><strong>Advantages</strong>:</p><p>Scale: One of the biggest perks of AI/ML is its ability to handle large datasets that would overwhelm traditional methods. When you're working with healthcare data, having a model that can process all that information at once is a game changer. Versatility: AI/ML can deal with different kinds of data time series, text, images, you name it whereas traditional stats might be limited to simpler, more structured data. Prediction: AI/ML models are often great at predicting outcomes, which is huge for things like identifying at-risk patients or forecasting trends in healthcare.</p><p><strong>Disadvantages</strong>:</p><p>Black-box issue: AI/ML models can be really accurate, but sometimes it’s hard to understand why<strong> </strong>the model made a particular prediction. This is where traditional biostatistics shines more transparency and easier to explain. Data dependency: AI/ML needs large, clean datasets to work well. In healthcare, it’s not always easy to get those kinds of datasets, so the models might not be as effective without that foundation. Overfitting: One issue I’ve seen with AI models is that they can overfit to the training data, making them less reliable on new data. It’s a lot of trial and error to get it just right.</p><p>Sadaf Ghaderzadeh, PhD</p>]]></description>
         <enclosure url="" />
         <pubDate>2025-02-12 18:14:11 UTC</pubDate>
         <guid>https://padlet.com/CarolynKelley/mqro75rxkpnxq68u/wish/3326214050</guid>
      </item>
      <item>
         <title>How does the integration of AI into clinical workflows highlight the need for collaboration between data scientists, clinicians, and administrators?</title>
         <author></author>
         <link>https://padlet.com/CarolynKelley/mqro75rxkpnxq68u/wish/3326218601</link>
         <description><![CDATA[<p>Bringing AI into clinical workflows is all about teamwork. It’s not just about building a great AI model; it’s about how well that model fits into real-life patient care. Clinicians bring the hands-on experience and context to the table, making sure that the AI tool actually aligns with patient needs and clinical goals. Data<strong> </strong>scientists need to work closely with clinicians to make sure the models are useful, practical, and grounded in reality. On the admin<strong> </strong>side, there’s a lot of behind-the-scenes work to make sure that the AI tools are compliant, cost-effective, and actually make sense within the hospital's operations. It’s this mix of expertise that’s key to making AI work in healthcare.</p><p>Sadaf Ghaderzadeh, PhD</p>]]></description>
         <enclosure url="" />
         <pubDate>2025-02-12 18:18:02 UTC</pubDate>
         <guid>https://padlet.com/CarolynKelley/mqro75rxkpnxq68u/wish/3326218601</guid>
      </item>
      <item>
         <title>Discussion</title>
         <author></author>
         <link>https://padlet.com/CarolynKelley/mqro75rxkpnxq68u/wish/3329193463</link>
         <description><![CDATA[<ol><li><p>Determining what patients are at a greater risk for readmission due to heart failure can potentially save lives. Patients who need additional care can be provided the attention they need to address potential concerns before readmission needs to occur. Healthcare systems benefit financially, but they will also have additional rooms and resources available for other patients facing other issues. </p></li><li><p>Advantages: personalization, speed, multiple model types, and multiple uses. Disadvantages: Bias/ethical concerns, data quality, and data complexity.</p></li><li><p>Collaboration between data scientists, clinicians, and administrators is essential for AI integration in clinical settings. There must be individuals that can develop the models and understand the feasibility of the technology, individuals that have the medical expertise to advise what features should be used while also having an understanding of the patients' needs, and lastly the administrator should not only advocate for the patients but they should also have an understanding of how the facility can safely integrate this technology. </p></li></ol><p><br/></p><ul><li><p>Armisha Roberts</p></li></ul>]]></description>
         <enclosure url="" />
         <pubDate>2025-02-14 17:47:31 UTC</pubDate>
         <guid>https://padlet.com/CarolynKelley/mqro75rxkpnxq68u/wish/3329193463</guid>
      </item>
      <item>
         <title>AI/ML RW Application</title>
         <author></author>
         <link>https://padlet.com/CarolynKelley/mqro75rxkpnxq68u/wish/3333263188</link>
         <description><![CDATA[<ul><li><p>Why is predicting hospital readmission for heart failure patients important for patient outcomes and healthcare systems?</p><ul><li><p>Patients with heart failure are already subject to adverse outcomes. By predicting hospital readmission, we can alleviate the burden of these adverse events, potentially preventing fatalities and improving standard of care in our healthcare systems.</p></li></ul></li><li><p>What are the advantages and disadvantages of using data science (AI/ML) models compared to traditional biostatistics?</p><ul><li><p>the advantages of AI/ML include, but are not limited to the ability to handle complex and non-linear models, high dimensional data, scalability and predictive performance</p></li><li><p>the downsides are things such as interpretability that traditional methods offer, the risks of overfitting models based on how they were trained, and of course the computational complexity and intensity</p></li></ul></li><li><p>How does the integration of AI into clinical workflows highlight the need for collaboration between data scientists, clinicians, and administrators?</p><ul><li><p>AI/ML into the clinical world serves as a beautiful reminder for the necessity of collaboration. Even similar fields such as bioinformatics and biostatistics have gaps that can benefit from being bridged by liaisons. When data scientists, clinicians, and admins can work together and truly try to understand one another, the benefits for healthcare are immeasureable. No one expert from one field is so in another, so to truly be able to maximize the benefit of each realm, collaboration is essential. </p></li></ul></li></ul><p><br/></p><p>Payton Mendygral</p>]]></description>
         <enclosure url="" />
         <pubDate>2025-02-18 20:05:34 UTC</pubDate>
         <guid>https://padlet.com/CarolynKelley/mqro75rxkpnxq68u/wish/3333263188</guid>
      </item>
   </channel>
</rss>
